Freeze-dried for stable storage and reconstituted by the receiving laboratory under its own protocols
Vasc Pharmacol
Medical Disclaimer: This is one persons experience with a research peptide not approved by the FDA for human therapeutic use
However, for patients with chronic illnesses, oxidative stress, or MTHFR gene mutations, this conversion process is often severely impaired, rendering cyanocobalamin largely ineffective for symptom management
For patients seeking weight loss who request B12 injections, GPs should: Assess for genuine deficiency through appropriate blood tests rather than empirical treatment Provide education about the lack of evidence supporting B12 for weight loss in non-deficient individuals Explore underlying concerns about weight and energy levels, addressing these through appropriate channels Signpost to evidence-based resources such as NHS weight management services according to local pathways Patients should contact their GP if they experience unexplained fatigue, neurological symptoms (numbness, tingling, balance problems), or signs of anaemia (pallor, breathlessness, palpitations), as these may indicate B12 deficiency requiring investigation
